Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy

Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative treatment for patients with myeloid malignancies such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). However, relapse and graft-versus-host disease (GvHD) still affect the survival of patien...

Full description

Bibliographic Details
Main Authors: Guancui Yang, Xiang Wang, Shiqin Huang, Ruihao Huang, Jin Wei, Xiaoqi Wang, Xi Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
hematopoietic stem cell transplantation
epigenetic therapy
graft-versus-host disease
myelodysplastic syndrome
acute myeloid leukemia
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1034438/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1034438/full

Similar Items